NCT05567809View on ClinicalTrials.gov

Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement (DEFINE-TAVR) Study.

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

October 25, 2022

Primary Completion Date

January 21, 2025

Study Completion Date

January 21, 2025

Conditions
Aortic Valve Stenosis
Trial Locations (1)

06510

Yale New Haven Hospital, New Haven

Sponsors
All Listed Sponsors
collaborator

Anteris Technologies Corporation

UNKNOWN

lead

Yale University

OTHER

NCT05567809 - Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement (DEFINE-TAVR) Study. | Biotech Hunter | Biotech Hunter